CSG, Stock

CSG Stock Stages 14% Weekly Rebound as Q1 Orders Hit €17bn and €58bn Slovakia Deal Hinges on EU Deadline

23.05.2026 - 19:02:25 | boerse-global.de

Defence contractor CSG posts 13.8% revenue growth, rebuts short-seller claims, but stock still 45% below peak. A €58bn Slovak ammunition framework hinges on EU SAFE deadline this month.

CSG Stock Stages 14% Weekly Rebound as Q1 Orders Hit €17bn and €58bn Slovakia Deal Hinges on EU Deadline - Bild: über boerse-global.de
CSG Stock Stages 14% Weekly Rebound as Q1 Orders Hit €17bn and €58bn Slovakia Deal Hinges on EU Deadline - Bild: über boerse-global.de

A sharp recovery this week has lifted shares in Czechoslovak Group (CSG) by 14%, but the defence contractor still trades almost 45% below its January peak. The bounce came after first-quarter earnings provided solid rebuttals to recent short-seller allegations, while traders now eye a looming European Union financing deadline that could unlock a massive Slovak ammunition framework.

Revenue for the three months to March reached €1.544bn, up 13.8% year-on-year, powered by the Defence Systems segment which surged 26.5% and more than made up for weaknesses elsewhere. Operating EBIT came in at €372m, translating to a 24.1% margin — comfortably within management’s full-year target range. The order backlog swelled to €17bn, a 15.1% increase since the start of the year, with a further €27bn pipeline under negotiation, driven by long-term contracts with NATO allies and Southeast Asian partners.

Not all segments shared the spoils. The Ammo+ unit, which houses the Kinetic Group ammunition business, saw revenue tumble 20.5% to €291m and operating profit crater 68.5% to just €13m, hit by soft civilian demand in the US. CSG acknowledged difficult conditions across the Atlantic but pointed to growing opportunities: the FBI has expanded its supply relationship with the group, and MSM North America is pursuing a $635m contract to design and build the US Army’s Future Artillery Complex in Iowa. New anti-drone ammunition, tested successfully with the Italian army, also entered the product lineup in April.

Balance sheet pressures eased noticeably. Net debt fell to €2.228bn from €3.004bn at year-end, a move that helped Moody’s lift CSG’s secured senior debt rating one notch to Baa3 from Ba1; Fitch reaffirmed its BBB- rating with a stable outlook. The improved financial profile strengthens the group’s hand as it pursues a massive potential deal in Slovakia.

Should investors sell immediately? Or is it worth buying CSG?

Through its ZVS Holding subsidiary, CSG has signed a framework agreement with the Slovak defence ministry for ammunition deliveries worth up to €58bn. No firm orders have been placed yet, and the company stresses the arrangement is not contingent on any single funding source. However, the most attractive financing option — the EU’s SAFE programme offering 40-year loans at 1% interest — requires at least one additional EU partner. Romania has already declined, and Croatia is still weighing its participation. The special dispensation allowing individual countries to use SAFE expires at the end of May, making the coming days critical.

The stock closed Friday at €18.70, down 3.4% on the session, but still posted a weekly gain of 14.14%. That leaves the shares 18.9% above their May 4 trough of €15.73, which followed a devastating report from Hunterbrook Media that accused CSG of merely refurbishing old ammunition rather than producing new shells. The company formally rejected the claims, describing them as a selective reading of public data designed to benefit a linked short position. Despite the rebound, the stock remains 14.6% below its 50-day moving average, a sign that volatility and scepticism persist.

Analysts, however, remain firmly bullish. The average 12-month price target stands at €32.85, with a range of €25 to €42, and all ten covering analysts rate the stock a Buy. For the full year, CSG reaffirmed guidance for revenue between €7.4bn and €7.6bn and an adjusted EBIT margin of 24–25%. A concrete production target underpins the growth narrative: the group aims to expand large-calibre ammunition capacity to 850,000 rounds per year by December.

CSG at a turning point? This analysis reveals what investors need to know now.

With the EU deadline fast approaching and the next scheduled corporate event not until half-year results on August 7, near-term attention will focus squarely on whether Slovakia can secure a second partner in time. If it does, the catalyst could be powerful enough to help CSG close the yawning gap to its previous highs.

Ad

CSG Stock: New Analysis - 23 May

Fresh CSG information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated CSG analysis...

en | NL0015073TS8 | CSG | boerse | 69408490 |